Involvement of inducible nitric oxide synthase and estrogen receptor ESR2 (ERβ) in the vascular dysfunction in female type 1 diabetic rats

Life Sciences

Volumn 216, Issue , 2019, Pages 279-286

  Sartoretto, Simone Marcieli ^a   Santos, Fernanda Fernandes ^a   Costa, Beatriz Pereira ^a   Ceravolo, Graziela Scalianti ^b   Santos Eichler, Rosângela ^a   Carvalho, Maria Helena Catelli ^a   Fortes, Zuleica Bruno ^a   Akamine, Eliana Hiromi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Diabetes; Female rats; iNOS; Vascular contraction

Indexed keywords

ALLOXAN; ENZYME INHIBITOR; ESTROGEN RECEPTOR 2 ANTAGONIST; ESTROGEN RECEPTOR BETA; GLUCOSE; HORMONE ANTAGONIST; INDUCIBLE NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NORADRENALIN; PROTEIN; S NITROSYLATED PROTEIN; UNCLASSIFIED DRUG; NOS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTIC CONSTRICTION; AORTIC ENDOTHELIUM; AORTIC SMOOTH MUSCLE CELL; ARTICLE; BLOOD VESSEL INJURY; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HEART MUSCLE CONTRACTILITY; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; NITROSYLATION; NONHUMAN; PATHOGENESIS; PLASMA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE DYSFUNCTION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR ENDOTHELIUM; WISTAR RAT;

ALLOXAN; ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; ESTROGEN RECEPTOR BETA; FEMALE; INFLAMMATION; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR;

EID: 85056739162     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2018.11.030     Document Type: Article

References (43)

1. Gray, S.P., Jandeleit-Dahm, K., The pathobiology of diabetic vascular complications-cardiovascular and kidney disease. J. Mol. Med. 92 (2014), 441–452 Berl.
2. El-Beblawy, N.M., Andrawes, N.G., Ismail, E.A., et al. Serum and urinary orosomucoid in young patients with type 1 diabetes: a link between inflammation, microvascular complications, and subclinical atherosclerosis. Clin. Appl. Thromb. Hemost. 22 (2016), 718–726.
3. Lowe, G., Woodward, M., Hillis, G., et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 63 (2014), 1115–1123.
4. Akamine, E.H., Kawamoto, E.M., Scavone, C., et al. Correction of endothelial dysfunction in diabetic female rats by tetrahydrobiopterin and chronic insulin. J. Vasc. Res. 43 (2006), 309–320.
5. Akamine, E.H., Urakawa, T.A., de Oliveira, M.A., et al. Decreased endothelium-dependent vasodilation in diabetic female rats: role of prostanoids. J. Vasc. Res. 43 (2006), 401–410.
6. Eppens, M.C., Craig, M.E., Cusumano, J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29 (2006), 1300–1306.
7. Edith-Rodriguez, J., Resendiz-Albor, A.A., Arciniega-Martinez, I.M., et al. Effect of early diabetes on the expression of alpha-1 adrenergic receptors in aorta and carotid arteries of Wistar Kyoto and spontaneously hypertensive rats. Clin. Exp. Hypertens. 35 (2013), 389–395.
8. Maeda, C.Y., Fernandes, T.G., Timm, H.B., Irigoyen, M.C., Autonomic dysfunction in short-term experimental diabetes. Hypertension 26 (1995), 1100–1104.
9. Nagareddy, P.R., Xia, Z., McNeill, J.H., MacLeod, K.M., Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005), H2144–H2152.
10. Sartoretto, S.M., Santos-Eichler, R., de Cássia, A., Tostes, R., et al. Role of nitric oxide and endothelin in endothelial maintenance of vasoconstrictor responses in aortas of diabetic female rats. J. Diabetes 5 (2013), 197–206.
11. Cheng, X., Pang, C.C., Increased vasoconstriction to noradrenaline by 1400W, inhibitor of iNOS, in rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 484 (2004), 263–268.
12. Nagareddy, P.R., McNeill, J.H., MacLeod, K.M., Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Eur. J. Pharmacol. 611 (2009), 53–59.
13. Bolego, C., Cignarella, A., Zancan, V., et al. Diabetes abolishes the vascular protective effects of estrogen in female rats. Life Sci. 64 (1999), 741–749.
14. Hu, G., DECODE Study Group, Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46 (2003), 608–617.
15. Legato, M.J., Gelzer, A., Goland, R., et al. Gender-specific care of the patient with diabetes: review and recommendations. Gend. Med. 3 (2006), 131–158.
16. Arnal, J.-F., Lenfant, F., Metivier, R., et al. Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications. Physiol. Rev. 97 (2017), 1045–1087.
17. Bolego, C., Cignarella, A., Sanvito, P., et al. The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation. J. Pharmacol. Exp. Ther. 313 (2005), 1203–1208.
18. Meyer, M.R., Prossnitz, E.R., Barton, M., The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vasc. Pharmacol. 55 (2011), 17–25.
19. Vegeto, E., Bonincontro, C., Pollio, G., et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21 (2001), 1809–1818.
20. Cignarella, A., Minici, C., Bolego, C., et al. Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr. Metab. Cardiovasc. Dis. 16 (2006), 322–329.
21. Freitas, H.S., Schaan, B.D., Seraphim, P.M., et al. Acute and short-term insulin-induced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats. Mol. Cell. Endocrinol. 237 (2005), 49–57.
22. Soliman, H., Craig, G.P., Nagareddy, P., et al. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Cardiovasc. Res. 79 (2008), 322–330.
23. Romero-Calvo, I., Ocón, B., Martínez-Moya, P., et al. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal. Biochem. 401 (2010), 318–320.
24. Callera, G.E., Touyz, R.M., Tostes, R.C., et al. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension 45 (2005), 773–779.
25. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
26. Quan, A., Pan, Y., Singh, K.K., et al. Cardiovascular inflammation is reduced with methotrexate in diabetes. Mol. Cell. Biochem. 432 (2017), 159–167.
27. Soares, A.G., Carvalho, M.H.C., Akamine, E., Obesity induces artery-specific alterations: evaluation of vascular function and inflammatory and smooth muscle phenotypic markers. Biomed. Res. Int., 2017, 10.1155/2017/5038602.
28. Zhang, M.L., Zheng, B., Tong, F., et al. iNOS-derived peroxynitrite mediates high glucose-induced inflammatory gene expression in vascular smooth muscle cells through promoting KLF5 expression and nitration. Biochim. Biophys. Acta 1863 (2017), 2821–2834.
29. Beasley, D., Schwartz, J.H., Brenner, B.M., Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87 (1991), 602–608.
30. Hecker, M., Cattaruzza, M., Wagner, A.H., Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells. Gen. Pharmacol. 32 (1999), 9–16.
31. Pacheco, M.E., Marín, J., Manso, A.M., et al. Nitric oxide synthase induction by ouabain in vascular smooth muscle cells from normotensive and hypertensive rats. J. Hypertens. 18 (2000), 877–884.
32. Wakabayashi, I., Nakano, T., Takahashi, Y., Enhancement of interleukin-1β-induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats. Eur. J. Pharmacol. 629 (2010), 1–6.
33. Su, C.F., Yang, F.L., Chen, H.I., Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats. Clin. Exp. Pharmacol. Physiol. 34 (2007), 339–346.
34. Takahashi, Y., Nakano, T., Wakabayashi, I., Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats. J. Pharm. Sci. 107 (2008), 190–200.
35. Brozovich, F.V., Nicholson, C.J., Degen, C.V., et al. Mechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disorders. Pharmacol. Rev. 68 (2016), 476–532.
36. Hess, D.T., Matsumoto, A., Kim, S.-O., et al. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6 (2005), 150–166.
37. Choi, H., Tostes, R.C., Webb, R.C., S-nitrosylation inhibits protein kinase C-mediated contraction in mouse aorta. J. Cardiovasc. Pharmacol. 57 (2011), 65–71.
38. Nozik-Grayck, E., Whalen, E.J., Stamler, J.S., et al. S-nitrosoglutathione inhibits α1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery. Am. J. Phys. Lung Cell. Mol. Phys. 290 (2006), L136–L143.
39. Bolego, C., Cignarella, A., Ruzza, R., et al. Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats. Life Sci. 60 (1997), 2291–2302.
40. Deer, R.R., Stallone, J.N., Effects of estrogen on cerebrovascular function: age-dependent shifts from beneficial to detrimental in small cerebral arteries of the rat. Am. J. Physiol. Heart Circ. Physiol. 310 (2016), H1285–H1294.
41. Ihionkhan, C.E., Chambliss, K.L., Gibson, L.L., et al. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ. Res. 91 (2002), 814–820.
42. Chakrabarti, S., Davidge, S.T., High glucose-induced oxidative stress alters estrogen effects on ERalpha and ERbeta in human endothelial cells: reversal by AMPK activator. J. Steroid Biochem. Mol. Biol. 117 (2009), 99–106.
43. Tsutsumi, S., Zhang, X., Takata, K., et al. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J. Endocrinol. 199 (2008), 267–273.